首页> 外文期刊>International journal of oncology >Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma
【24h】

Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma

机译:肌动蛋白相关蛋白2/3复合亚基5(ARPC5)促进细胞迁移和侵袭,并直接由头颈部鳞状细胞癌中的肿瘤抑制microRNA-133a调控。

获取原文
           

摘要

Our expression signatures of human cancers including head and neck squamous cell carcinoma (HNSCC) demonstrated that downregulation of microRNA-133a (miR-133a) were frequently observed in cancer cells. The restoration of miR-133a in cancer cells revealed that it functions as a tumor suppressor. In this study, we investigated the novel molecular targets of miR-133a in HNSCC cancer cells and its oncogenic function, especially as it contributes to cancer cell migration and invasion. The genome-wide gene expression analysis and bioinformatics study showed that actin-related protein 2/3 complex subunit?5 (ARPC5) is a candidate target of miR-133a. Furthermore, luciferase reporter assay demonstrated that ARPC5 is directly regulated by miR-133a. Silencing of ARPC5 revealed significant inhibition of cell migration and invasion in HNSCC cell lines, SAS, HSC3 and IMC-3. In HSC3 cells, restoration of miR-133a or silencing ARPC5 led to a reorganization of the actin cytoskeleton and a subsequent change in cell morphology to a round, bleb-like shape. The expression levels of ARPC5 were significantly higher in HNSCC tissues than in non-cancer tissues. Immunohistochemistry showed that the levels of ARPC5 expression were significantly higher in invasive cancer cells. ARPC5 contributed to cancer cell migration and invasion in HNSCC and this gene was directly regulated by miR-133a. Our analysis of novel tumor-suppressive miR?133a-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis.
机译:我们对包括头颈部鳞状细胞癌(HNSCC)在内的人类癌症的表达特征表明,在癌细胞中经常观察到microRNA-133a(miR-133a)的下调。癌细胞中miR-133a的还原表明它起着抑癌作用。在这项研究中,我们研究了miR-133a在HNSCC癌细胞中的新型分子靶标及其致癌功能,特别是它有助于癌细胞的迁移和侵袭。全基因组基因表达分析和生物信息学研究表明,肌动蛋白相关蛋白2/3复合亚基5(ARPC5)是miR-133a的候选靶标。此外,萤光素酶报告基因检测证明ARPC5直接受miR-133a调控。 ARPC5的沉默显示显着抑制HNSCC细胞系,SAS,HSC3和IMC-3中的细胞迁移和侵袭。在HSC3细胞中,miR-133a的恢复或ARPC5的沉默导致肌动蛋白细胞骨架的重组,并随后将细胞形态改变为圆形,小泡状。 HNSCC组织中ARPC5的表达水平显着高于非癌组织。免疫组织化学表明,侵袭性癌细胞中ARPC5表达水平明显更高。 ARPC5促进了癌细胞在HNSCC中的迁移和侵袭,而该基因直接受miR-133a调控。我们对新型的肿瘤抑制性miR?133a介导的癌症途径的分析为HNSCC肿瘤发生的潜在机制提供了新的见解。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号